Collegium Share Price

Collegium Share Price

NASDAQ: COLL | Small Cap | Healthcare
$25.95
+$0.39 (1.53%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Collegium Stock Performance

Open
$25.54
Prev. Close
$25.56
Circuit Range
N/A
Day Range
$25.54 - $26.18
Year Range
$21.45 - $49.97
Volume
29,369
Average Traded
$25.93

Collegium Share Price Today

As of 19 November 2026, Collegium Pharmaceutical, Inc.'s share price is $25.95. The stock opened at $25.54, compared to its previous close of $25.56. During today's trading session, Collegium Pharmaceutical, Inc.'s share price traded between $25.54 and $26.18, with an average price of $25.86. Over the past 52 weeks, the stock has recorded a high of $49.97 and a low of $21.45. In terms of performance, Collegium Pharmaceutical, Inc.'s share price has declined by 22.79% over the last six months and is down 44.36% on a year-on-year basis.

Collegium Share Price Chart

Line chart of the Collegium price trend over the selected period. The price rose overall, ranging from 25.20 to 26.24, ending at 25.95.
$25.54$26.18
L
Show Current Price
H

Collegium Stock Fundamentals & Key Indicators

Market Cap
$822.78M
PE Ratio (TTM)
20.80
Dividend Yield
0.00%
EPS (TTM)
$1.23
Revenue (TTM)
$780.57B
Return On Equity (TTM)
12.88%
Profit Margin
8.05%
Debt to Equity
3.65
Quarterly Earnings Growth YoY
28.30%

Collegium Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$205.45$193.52$199.88$216.34
Net Profit$16.96$14.50-$15.05$21.76
Net Profit Margin8.26%7.49%-7.53%10.06%
Income ChangeN/A-14.50%-203.79%244.58%

Collegium Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$463.93$566.77$631.45$780.57
Net Profit-$25.00$48.16$69.19$62.87
Net Profit Margin-5.39%8.50%10.96%8.05%
Income ChangeN/A292.64%43.67%-9.13%

Collegium Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets965.421181.33605.71754.14
Current Assets691.41482.26537.6419.99
Total Assets1656.831663.591143.311174.13
Non Current Liabilities915.13925.24489.96545.56
Current Liabilities440.03509.51457.92433.73
Total Liabilities1355.161434.75947.88979.29
Shareholders' Equity301.68228.84195.43194.84

Collegium Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating329.32204.98274.75124.23
Investing-63.53-287.76-70.81-573.69
Financing-110.25-60.6-140.18436.72

About Collegium

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Collegium Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$23.80
$25.93
+9.13%
Oct 2026
$21.88
$23.77
+8.59%
Sep 2026
$24.98
$21.89
-16.98%
Aug 2026
$35.44
$26.36
-25.56%
Jul 2026
$36.41
$35.41
-2.17%
Jun 2026
$33.08
$36.20
+7.69%
May 2026
$33.80
$33.61
-0.27%
Apr 2026
$33.22
$33.70
+2.03%
Mar 2026
$41.09
$33.03
-20.77%
Feb 2026
$46.90
$41.69
-9.25%
Jan 2026
$46.30
$45.94
-0.76%
Dec 2025
$46.75
$46.29
-0.74%

Collegium Share Price FAQs